Table 1 Weighted prevalence of socioeconomic and geographical characteristics and health preventive outcomes of the study population (2015 and 2018) *

N = 6915

%

N = 6184

%

Age group

15–24

2,874

41.57

2,624

42.44

25–39

2,838

41.04

2,453

39.68

40–49

1,202

17.39

1,106

17.89

Education

Completed Secondary School or higher than secondary

369

5.35

562

9.09

Completed Primary School

1,738

25.13

1,726

27.93

No education

4,807

69.52

3,895

62.98

Wealth Quintile

Richest

975

14.09

913

14.77

Richer

1,063

15.38

963

15.59

Middle

1,275

18.44

1,214

19.63

Poorer

1,696

24.52

1,481

23.96

Poorest

1,906

27.56

1,611

26.05

Residence

Urban

2,437

35.24

2,216

35.83

Rural

4,478

64.76

3,968

64.17

Region

Northern

2,442

35.31

2,044

33.07

Central

2,502

36.18

2,536

41.01

Southern

1,971

28.51

1,603

25.93

Outcomes

ITN Total sample

4756

100

4204

100

Non-ITN use

2425

51.01

990

23.55

Fever treatment total sample

1134

100

1144

100

Non-fever treatment

399

35.18

322

28.07

Fansidar total sample

3977

100

3524

100

Non-use of 3 Fansidar doses

3117

78.36

2126

60.33